-
-
-
-
-
-
-
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026
-
-
-
-
-
-
-
Aditxt, Inc (ADTX) Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
-
-
-
-
-
-
-
Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem
-
-
-
-
-
-
-
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2025
-
-
-
-
-
-
-
Appili Therapeutics Announces FY 2020 Annual and Financial Results
1,169,310 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

